Compile Data Set for Download or QSAR

Found 18 hits of ic50 data for polymerid = 50006337   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299240 (US9593121, I-03 | {(1S,2S,4R)-2-hydroxy-4-[4-(5-me...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2cc(OC)ccc2[nH]1 |^1:0| Show InChI InChI=1S/C21H21N4O2/c1-12-7-14(10-19(12)26)25-6-5-16-20(22-11-23-21(16)25)18-9-13-8-15(27-2)3-4-17(13)24-18/h3-6,8-9,11-12,14,19,24,26H,1,7,10H2,2H3/t12-,14+,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299259 (US9593121, I-08 | {(1S,2S,4R)-2-hydroxy-4-[4-(1H-i...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(nc(C)nc12)-c1cc2ccccc2[nH]1 |^1:0| Show InChI InChI=1S/C21H21N4O/c1-12-9-15(11-19(12)26)25-8-7-16-20(22-13(2)23-21(16)25)18-10-14-5-3-4-6-17(14)24-18/h3-8,10,12,15,19,24,26H,1,9,11H2,2H3/t12-,15+,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299243 (US9593121, I-06 | {(1S,2S,4R)-2-hydroxy-4-[4-(6-me...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2ccc(C)cc2[nH]1 |^1:0| Show InChI InChI=1S/C21H21N4O/c1-12-3-4-14-9-18(24-17(14)7-12)20-16-5-6-25(21(16)23-11-22-20)15-8-13(2)19(26)10-15/h3-7,9,11,13,15,19,24,26H,2,8,10H2,1H3/t13-,15+,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299242 (US9593121, I-05 | {(1S,2S,4R)-4-[4-(6-cyano-1H-ind...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2ccc(cc2[nH]1)C#N |^1:0| Show InChI InChI=1S/C21H18N5O/c1-12-6-15(9-19(12)27)26-5-4-16-20(23-11-24-21(16)26)18-8-14-3-2-13(10-22)7-17(14)25-18/h2-5,7-8,11-12,15,19,25,27H,1,6,9H2/t12-,15+,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299241 (US9593121, I-04 | {(1S,2S,4R)-4-[4-(6-chloro-1H-in...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2ccc(Cl)cc2[nH]1 |^1:0| Show InChI InChI=1S/C20H18ClN4O/c1-11-6-14(9-18(11)26)25-5-4-15-19(22-10-23-20(15)25)17-7-12-2-3-13(21)8-16(12)24-17/h2-5,7-8,10-11,14,18,24,26H,1,6,9H2/t11-,14+,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299236 (((1S,2S,4R)-4-(4-(1H-indol-2-yl)-7H-pyrrolo[2,3- d...) Show SMILES NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2ccccc2[nH]1 Show InChI InChI=1S/C20H21N5O4S/c21-30(27,28)29-10-13-7-14(9-18(13)26)25-6-5-15-19(22-11-23-20(15)25)17-8-12-3-1-2-4-16(12)24-17/h1-6,8,11,13-14,18,24,26H,7,9-10H2,(H2,21,27,28)/t13-,14+,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299257 (US9593121, I-07 | {(1S,2S,4R)-2-hydroxy-4-[4-(6-me...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2ccc(OC)cc2[nH]1 |^1:0| Show InChI InChI=1S/C21H21N4O2/c1-12-7-14(9-19(12)26)25-6-5-16-20(22-11-23-21(16)25)18-8-13-3-4-15(27-2)10-17(13)24-18/h3-6,8,10-12,14,19,24,26H,1,7,9H2,2H3/t12-,14+,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<50	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM50427035 (CHEMBL2017005) Show SMILES NS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N[C@H]3CCc4ccccc34)ncnc12 |r| Show InChI InChI=1S/C19H22N6O6S/c20-32(28,29)30-7-13-15(26)16(27)19(31-13)25-9-23-14-17(21-8-22-18(14)25)24-12-6-5-10-3-1-2-4-11(10)12/h1-4,8-9,12-13,15-16,19,26-27H,5-7H2,(H2,20,28,29)(H,21,22,24)/t12-,13+,15+,16+,19+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	920	n/a	n/a	n/a	n/a	n/a	n/a
University of Toronto Mississauga Curated by ChEMBL					Assay Description Inhibition of UBA6 (unknown origin) in presence of ATP				J Med Chem 56: 2165-77 (2013) Article DOI: 10.1021/jm301420b BindingDB Entry DOI: 10.7270/Q29P32ZT
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM50285607 (MLN-4924 | MLN-4924003 | Pevonedistat) Show SMILES [H][C@]1(O)C[C@@]([H])(C[C@@]1([H])COS(N)(=O)=O)n1ccc2c(N[C@@]3([H])CCc4ccccc34)ncnc12 |r| Show InChI InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem Similars	Article PubMed	n/a	n/a	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Temple University Curated by ChEMBL					Assay Description Inhibition of UBA6 (unknown origin) assessed as decrease in formation of E2-UBL thioester reaction product				J Med Chem 61: 3239-3252 (2018) Article DOI: 10.1021/acs.jmedchem.6b01817 BindingDB Entry DOI: 10.7270/Q2542R5N
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299322 (US9593121, I-14 | [(1S,2S,4R)-2-hydroxy-4-{4-[6-(t...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2ccc(cc2[nH]1)C(F)(F)F |^1:0| Show InChI InChI=1S/C21H18F3N4O/c1-11-6-14(9-18(11)29)28-5-4-15-19(25-10-26-20(15)28)17-7-12-2-3-13(21(22,23)24)8-16(12)27-17/h2-5,7-8,10-11,14,18,27,29H,1,6,9H2/t11-,14+,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03E+3	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299284 (US9593121, I-13 | {(1S,2S,4R)-2-hydroxy-4-[4-(3-me...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1[nH]c2ccccc2c1C |^1:0| Show InChI InChI=1S/C21H21N4O/c1-12-9-14(10-18(12)26)25-8-7-16-20(22-11-23-21(16)25)19-13(2)15-5-3-4-6-17(15)24-19/h3-8,11-12,14,18,24,26H,1,9-10H2,2H3/t12-,14+,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03E+3	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299282 (US9593121, I-12 | {(1S,2S,4R)-2-hydroxy-4-[4-(7-me...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2cccc(OC)c2[nH]1 |^1:0| Show InChI InChI=1S/C21H21N4O2/c1-12-8-14(10-17(12)26)25-7-6-15-20(22-11-23-21(15)25)16-9-13-4-3-5-18(27-2)19(13)24-16/h3-7,9,11-12,14,17,24,26H,1,8,10H2,2H3/t12-,14+,17-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03E+3	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299276 (US9593121, I-11 | {(1S,2S,4R)-4-[4-(5-fluoro-1H-in...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2cc(F)ccc2[nH]1 |^1:0| Show InChI InChI=1S/C20H18FN4O/c1-11-6-14(9-18(11)26)25-5-4-15-19(22-10-23-20(15)25)17-8-12-7-13(21)2-3-16(12)24-17/h2-5,7-8,10-11,14,18,24,26H,1,6,9H2/t11-,14+,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03E+3	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299265 (US9593121, I-10 | tert-butyl 2-(7-{(1R,3S,4S)-3-hy...) Show SMILES COc1ccc2cc(-c3ncnc4n(ccc34)[C@H]3C[C@H](O)[C@H](COS(N)(=O)=O)C3)n(C(=O)OC(C)(C)C)c2c1 Show InChI InChI=1S/C26H31N5O7S/c1-26(2,3)38-25(33)31-20-12-18(36-4)6-5-15(20)10-21(31)23-19-7-8-30(24(19)29-14-28-23)17-9-16(22(32)11-17)13-37-39(27,34)35/h5-8,10,12,14,16-17,22,32H,9,11,13H2,1-4H3,(H2,27,34,35)/t16-,17+,22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03E+3	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299263 (US9593121, I-09 | {(1S,2S,4R)-4-[4-(6-chloro-5-flu...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2cc(F)c(Cl)cc2[nH]1 |^1:0| Show InChI InChI=1S/C20H17ClFN4O/c1-10-4-12(7-18(10)27)26-3-2-13-19(23-9-24-20(13)26)17-6-11-5-15(22)14(21)8-16(11)25-17/h2-3,5-6,8-10,12,18,25,27H,1,4,7H2/t10-,12+,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03E+3	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM299237 (US9593121, I-02 | {(1S,2S,4R)-2-hydroxy-4-[4-(1-me...) Show SMILES [CH2][C@H]1C[C@H](C[C@@H]1O)n1ccc2c(ncnc12)-c1cc2ccccc2n1C |^1:0| Show InChI InChI=1S/C21H21N4O/c1-13-9-15(11-19(13)26)25-8-7-16-20(22-12-23-21(16)25)18-10-14-5-3-4-6-17(14)24(18)2/h3-8,10,12-13,15,19,26H,1,9,11H2,2H3/t13-,15+,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03E+3	n/a	n/a	n/a	n/a	n/a	n/a
Millennium Pharmaceuticals, Inc. US Patent					Assay Description The UBA6 enzmatic reaction totals 20 μL and contains 50 mM HEPES (pH 7.5), 0.05% BSA, 0.02% Tween 20, 0.1 mM TCEP, 5 mM MgCl2, 2 μM ATP, 60...				US Patent US9593121 (2017) BindingDB Entry DOI: 10.7270/Q24F1SSJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM50285607 (MLN-4924 | MLN-4924003 | Pevonedistat) Show SMILES [H][C@]1(O)C[C@@]([H])(C[C@@]1([H])COS(N)(=O)=O)n1ccc2c(N[C@@]3([H])CCc4ccccc34)ncnc12 |r| Show InChI InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem Similars	Article PubMed	n/a	n/a	1.80E+3	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1016/j.ejmech.2022.114156 BindingDB Entry DOI: 10.7270/Q21C21WJ
					More data for this Ligand-Target Pair
Ubiquitin-like modifier-activating enzyme 6 (Homo sapiens (Human))	BDBM50427034 (CHEMBL2322194) Show SMILES NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)N1CCc2c1ncnc2N[C@H]1CCc2ccccc12 |r| Show InChI InChI=1S/C21H27N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,12,14-15,18-19,27H,5-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.80E+3	n/a	n/a	n/a	n/a	n/a	n/a
University of Toronto Mississauga Curated by ChEMBL					Assay Description Inhibition of UBA6 (unknown origin)				J Med Chem 56: 2165-77 (2013) Article DOI: 10.1021/jm301420b BindingDB Entry DOI: 10.7270/Q29P32ZT
					More data for this Ligand-Target Pair